Author:
De Castro Laurie,Manoury Annabelle,Claude Olivier,Simoneau Bastien,Monceau Virginie,Suhard David,Elie Christelle,Magneron Victor,Roy Laurence,Bouvier-Capely Céline,Ibanez Chrystelle,Davesne Estelle,Guéguen Yann
Abstract
AbstractDuring nuclear fuel processing, workers can potentially be exposed to repeated inhalations of uranium compounds. Uranium nephrotoxicity is well documented after acute uranium intake, but it is controversial after long-term or protracted exposure. This study aims to analyze the nephrotoxicity threshold after repeated uranium exposure through upper airways and to investigate the resulting uranium biokinetics in comparison to reference models. Mice (C57BL/6J) were exposed to uranyl nitrate (0.03–3 mg/kg/day) via intranasal instillation four times a week for two weeks. Concentrations of uranium in urines and tissues were measured at regular time points (from day 1 to 91 post-exposure). At each exposure level, the amount of uranium retained in organs/tissues (kidney, lung, bone, nasal compartment, carcass) and excreta (urine, feces) reflected the two consecutive weeks of instillation except for renal uranium retention for the highest uranium dose. Nephrotoxicity biomarkers, KIM-1, clusterin and osteopontin, are induced from day 4 to day 21 and associated with changes in renal function (arterial fluxes) measured using non-invasive functional imaging (Doppler-ultrasonography) and confirmed by renal histopathological analysis. These results suggest that specific biokinetic models should be developed to consider altered uranium excretion and retention in kidney due to nephrotoxicity. The threshold is between 0.25 and 1 mg/kg/day after repeated exposure to uranium via upper airways.
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. Stradling, G. N. et al. Factors affecting the abundance of uranium isotopes in body tissues and excreta following the deposition of enriched uranium dioxide in the lungs–the radiological implications. Health Phys. 46, 434–438 (1984).
2. Gueguen, Y. et al. Biomarkers for uranium risk assessment for the development of the CURE (Concerted Uranium Research in Europe) molecular epidemiological protocol. Radiat. Res. 187, 107–127. https://doi.org/10.1667/RR14505.1 (2017).
3. Ansoborlo, E. et al. Actinide speciation in relation to biological processes. Biochimie 88, 1605–1618. https://doi.org/10.1016/j.biochi.2006.06.011 (2006).
4. Bontemps, A. et al. In vivo comparison of the phenotypic aspects and molecular mechanisms of two nephrotoxic agents, sodium fluoride and uranyl nitrate. Int. J. Environ. Res. Public Health https://doi.org/10.3390/ijerph16071136 (2019).
5. Haley, D. P., Bulger, R. E. & Dobyan, D. C. The long-term effects of uranyl nitrate on the structure and function of the rat kidney. Virchows Arch. B 41, 181–192 (1982).